Polymorphisms in CYP3A5* 3 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients.

Annals of transplantation, 2011 - europepmc.org
Background The purpose of this study was to investigate the effects of polymorphisms in
CYP3A5* 3, CYP3AP1, and MDR1, and of haplotype, on plasma levels of tacrolimus in …
被引用次数：39 相关文章

Polymorphisms in CYP3A5* 3 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients

P Wu, X Ni, M Wang, X Xu, G Luo… - Annals of …, 2011 - pubmed.ncbi.nlm.nih.gov
Background The purpose of this study was to investigate the effects of polymorphisms in
CYP3A5* 3, CYP3AP1, and MDR1, and of haplotype, on plasma levels of tacrolimus in …

Polymorphisms in CYP3A5* 3 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients

P Wu, X Ni, M Wang, X Xu, G Luo, Y Jiang - Annals of Transplantation, 2011 - hero.epa.gov
BACKGROUND: The purpose of this study was to investigate the effects of polymorphisms in
CYP3A5* 3, CYP3AP1, and MDR1, and of haplotype, on plasma levels of tacrolimus in …